Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » Archive by category 'Cancer Options'


You are currently browsing the archives for the
Cancer Options category.

Articles and advice that talk about different treatment options available for those with cancer.

New Web Site Helps Doctors And Prostate Cancer Patients Make Better Treatment Choices

ScienceDaily (Sep. 23, 2008) — Doctors have created a free online computer tool, the CaP Calculator, that provides cancer specialists access to the latest prostate cancer research and helps them better individiualize each patient’s treatment options, according to a study presented in a scientific session on September, 23, 2008, at the American Society for Therapeutic […]

 

September is Prostate Cancer Awareness Month

Doctors will diagnose more than 186,000 US men with prostate cancer this year.
And, each patient will have to weigh their treatment options and learn more about the diagnosis.
That’s why September has been declared National Prostate Cancer Awareness Month - spot lighting this highly treatable disease.
Prostate cancer is the most common non-skin cancer in America, affecting […]

 

MRI combo spots prostate cancer treatment failure

Two imaging modalities used in combination — dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI — can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.Together these two imaging modalities are better than either modality alone, researchers say.
High-intensity […]

 

Prostate Cancer Hormone Therapy Treatment Questioned

Hormone therapy, an aggressive treatment for prostate cancer, may be overused, a new study suggests.Treatment used to reduce the size of the prostate has been shown to improve survival in advanced cancers, but doctors have increasingly been giving hormone therapy in less-severe cases.
The study, published in this week’s New England Journal of Medicine, charted the […]

 

Chemo Break Benefits Some Men With Prostate Cancer

FRIDAY, Feb. 29 (HealthDay News) — Some men with advanced prostate cancer can safely take a break from chemotherapy, says a study by researchers at the Oregon Health & Science University Cancer Institute.The study included 250 men with metastatic, androgen-independent prostate cancer — disease that spreads from the prostate and isn’t affected by the male […]

 

Unproven cancer therapy lures U.S. men to Mexico

Article from The New York Times
By Stephanie Saul
PUERTO VALLARTA, Mexico - Some weekends, more than a dozen American men wait at beachfront hotels, eager for their turns in the treatment room at a small private hospital here.
They are medical tourists with prostate cancer. And they are queued up for the latest therapy - one advertised […]

 

ASTRO’s 49th annual meeting of radiation oncology

ProxcelanTM (Cesium-131) is the newest advancement in permanent brachytherapy seed implants for prostate cancerLOS ANGELES, CA - Several newly released scientific findings focusing on various aspects of ProxcelanTM (Cesium-131) seeds’ effectiveness in the treatment of prostate cancer–supporting and broadening the growing body of evidence on the newest medical isotope being used in permanent seed therapy.
The […]

 

Proxcelan™ with Cesium-131 advantages

Proxcelan™ (Cesium-131) brachytherapy seeds offer patients unique advantages over other medical isotopes. Increasingly, prostate cancer patients and their doctors who decide on seed brachytherapy choose Cesium-131 treatment because of its significant advantages over Palladium-103 and Iodine-125, two other isotopes currently in use. These advantages include Higher Energy, Shorter Half-Life, and Higher Biologically Effective Dose.
For […]

 

Newest isotope used in brachytherapy for prostate cancer

FOR IMMEDIATE RELEASE: July 20, 2007
Scientific abstracts on the newest isotope used in brachytherapy for prostate cancer–IsoRay Medical’s Proxcelan™ with Cesium-131–presented at the American Association of Physicists in Medicine (AAPM) annual conference, July 22-26
RICHLAND, Washington - Noted medical researchers from around the country will gather at the 26th annual American Association of […]

 

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    High fat diet may abet prostate cancer progression

  • By Joene Hendry NEW YORK (Reuters Health) - Diets high in saturated fat may increase the risk of prostate cancer progression, researchers from the University of Texas M. D. Anderson Cancer Center in Houston report. In a follow up study of men who had their cancerous

    • Novel Therapy May Prove Effective In Treatment Of 30 Percent Of Cancers

  • Novel Therapy May Prove Effective In Treatment Of 30 Percent Of Cancers A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of

    • Early Screening Reduces Disparities For Prostate Cancer

  • Early Screening Reduces Disparities For Prostate Cancer Men who have a regular, ongoing relationship with a health care provider are more likely to receive prostate cancer screening and less likely to be diagnosed with advanced prostate cancer, regardless of their race, according

    • New Web Site Helps Doctors And Prostate Cancer Patients Make Better Treatment Choices

  • ScienceDaily (Sep. 23, 2008) — Doctors have created a free online computer tool, the CaP Calculator, that provides cancer specialists access to the latest prostate cancer research and helps them better individiualize each patient's treatment options, according to a study presented in a scientific session on September, 23, 2008, at

    • Contact

  • Lori Woods 350 Hills Street, Suite 106 Richland, WA 99354 Phone (509) 375-1202 Email: lwoods@isoray.com

    • Caution Advised When Using Hormone Therapy for Prostate Cancer

  • In men with localized but aggressive prostate cancer, the combination of testosterone-lowering therapy and radiation improves survival substantially more than radiation therapy alone. But testosterone-lowering therapy isn’t so hot for the heart, reports the April issue of the Harvard Heart Letter. Low testosterone can increase harmful LDL cholesterol, blood sugar,

    • Prostate Cancer Most Common Cause of Cancer Deaths in Jamaican Men

  • Prostate cancer is the most common cause of cancer deaths in Jamaican men. If caught at an early, localised stage, prostate cancer is curable. Even advanced cancer can be treated with drugs made more available under the National Health Fund.Yet, it is estimated that 40 per cent of men with

    • Lowering Cholesterol May Also Lower Prostate Cancer Risk

  • WEDNESDAY, May 21 (HealthDay News) -- Men who keep their cholesterol down might also help lower their levels of prostate specific antigen, a protein that can warn of prostate cancer, a new study says."Prostate cancer is controlled by the male hormone testosterone. The main molecule that forms testosterone is

    • Newest isotope used in brachytherapy for prostate cancer

  • FOR IMMEDIATE RELEASE: July 20, 2007 Scientific abstracts on the newest isotope used in brachytherapy for prostate cancer--IsoRay Medical’s Proxcelan™ with Cesium-131--presented at the American Association of Physicists in Medicine (AAPM) annual conference, July 22-26 RICHLAND, Washington - Noted medical researchers from around the country will gather at the

    • Proxcelan™ with Cesium-131 advantages

  • Proxcelan™ (Cesium-131) brachytherapy seeds offer patients unique advantages over other medical isotopes. Increasingly, prostate cancer patients and their doctors who decide on seed brachytherapy choose Cesium-131 treatment because of its significant advantages over Palladium-103 and Iodine-125, two other isotopes currently in use. These advantages include Higher Energy, Shorter Half-Life,


  •  

    March 2010
    M T W T F S S
    « Jan    
    1234567
    891011121314
    15161718192021
    22232425262728
    293031  
images